Sale Price:
$85.00
Original Price:
$90.00
Each vial contains 20mg of highly pure Tirzepatide.
Tirzepatide activates both GIP and GLP-1 receptors at the same time. Semaglutide only hits one of those (GLP-1). That second pathway — GIP — adds a separate layer of metabolic signaling that affects how the body handles insulin sensitivity, nutrient processing, and energy balance. Published clinical trials showed this dual approach outperformed single-pathway compounds at comparable timepoints.
It sits right in the middle of the incretin hierarchy: semaglutide covers one pathway, tirzepatide covers two, and retatrutide covers three. That makes tirzepatide the key middle piece for understanding what GIP receptor engagement actually adds to the equation — without the added complexity of a third receptor.
Each vial contains 20mg of highly pure Tirzepatide.
Tirzepatide activates both GIP and GLP-1 receptors at the same time. Semaglutide only hits one of those (GLP-1). That second pathway — GIP — adds a separate layer of metabolic signaling that affects how the body handles insulin sensitivity, nutrient processing, and energy balance. Published clinical trials showed this dual approach outperformed single-pathway compounds at comparable timepoints.
It sits right in the middle of the incretin hierarchy: semaglutide covers one pathway, tirzepatide covers two, and retatrutide covers three. That makes tirzepatide the key middle piece for understanding what GIP receptor engagement actually adds to the equation — without the added complexity of a third receptor.
Image 1 of 1